- TWD11.22bn
- TWD11.37bn
- TWD4.08bn
- 66
- 29
- 98
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,432 | 5,466 | 4,674 | 4,983 | 4,082 |
Cost of Revenue | |||||
Gross Profit | 914 | 1,148 | 925 | 1,122 | 994 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 4,004 | 4,918 | 4,368 | 4,480 | 3,705 |
Operating Profit | 428 | 548 | 306 | 503 | 378 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 424 | 551 | 323 | 576 | 410 |
Provision for Income Taxes | |||||
Net Income After Taxes | 327 | 417 | 240 | 453 | 321 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 289 | 372 | 220 | 428 | 323 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 289 | 375 | 221 | 430 | 323 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.28 | 5.18 | 2.95 | 5.73 | 4.38 |
Dividends per Share |